This corresponded to elevated plasma levels of GDF15, starting from the early myopathy stage and increasing with age (3‐, 6‐, and 16‐fold change at 50, 100, and 200 days, respectively, Fig 4L). The gene discussed is GDF15; the disease is myopathy.